- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
The Scientific World Journal
Volume 2013 (2013), Article ID 460202, 7 pages
A New gcrR-Deficient Streptococcus mutans Mutant for Replacement Therapy of Dental Caries
1The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-Most) & Key Laboratory for Oral Biomedical Engineering of Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan 430079, China
2Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei 430060, China
Received 20 August 2013; Accepted 17 September 2013
Academic Editors: U. S. Gaipl, T. Kizaki, and R. G. Palma-Dibb
Copyright © 2013 Wenting Pan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. gcrR gene acts as a negative regulator related to sucrose-dependent adherence in S. mutans. It is constructive to test the potential capacity of mutans with gcrR gene deficient in bacteria replacement therapy. Methods. In this study, we constructed the mutant by homologous recombination. The morphological characteristics of biofilms were analyzed by confocal laser scanning microscopy. S. mutans UA159 and the mutant MS-gcrR-def were inoculated, respectively, or together for competitive testing in vitro and in rat model. Results. Adhesion assay showed that the adhesion ability of the mutant increased relative to the wild type, especially in the early stage. MS-gcrR-def out-competed S. mutans UA159 in vitro biofilm, and correspondingly coinfection displayed significantly fewer caries in vivo. The former possessed both a lower level of acid production and a stronger colonization potential than S. mutans UA159. Conclusion. These findings demonstrate that MS-gcrR-def appears to be a good candidate for replacement therapy.
Dental caries is a well known major oral health problem in most countries. According to a national survey of the oral health status in China in 2005, more than 50% of children aged 7 years were affected by dental caries . Although fluoride and other preventive methods have resulted in the decrease in dental caries, little effort has been devoted to addressing this actual pathogen that causes the infection because the oral cavity is a complex ecosystem, in which a rich and diverse microbiota has evolved. Methods such as whole bacteria replacement therapy are continuously developed to eliminate the pathogenic members of the oral cavity.
The concept of bacteria replacement therapy against dental caries has been put up early in the middle of last century , related to none or less virulent strains of tooth-cloning bacteria preempting the tooth surface and replacing the more cariogenic counterparts. Many relatively nonpathogenic oral commensals found in high numbers at oral cavity have been suggested as a replacement or interference organism, such as Streptococcus sanguis , Streptococcus gordonii [4, 5], and Streptococcus salivarius . Unfortunately, those succedaneums cannot compete with Streptococcus mutans (S. mutans, MS) and failed in replacement therapy. The attempts to search an appropriate strain to prevent caries became focused on gene-modulation for the main pathogen, MS.
S. mutans is recognized as the main pathogen of dental caries in humans. In the procession development of caries, the paramount main virulence factor involves the ability to produce acid and adhere to the tooth surface . In particular, the sucrose-dependent adherence of S. mutans to the tooth surface prevents the bacteria from being washed away by chewing or by the flow of saliva. The rationale of the sucrose-dependent adherence can be used by the low acid-producing strains to enhance their adherence ability. Thus, these strains occupy the same ecological niche in plaque similar to their more cariogenic progenitor . Idone generated a mutant with gene gcrR knock out, a gene regulated with sucrose-dependent adherence of S. mutans, called GMS900 . The study showed an enhancement in gene expression related to sucrose-dependent adherence in vivo, as well as significantly fewer cavities on it, which suggest the capacity of replacement therapy.
In the present study, we constructed gcrR-deficient S. mutans mutant and confirmed its ability of replacement therapy both in vitro and in vivo. This study demonstrated that the mutant strain, which lacks the whole open reading frame (ORF) of the gcrR gene, had lower acid production and stronger colonization potential compared with the wild-type strain.
2. Material and Methods
2.1. Bacterial Strains and Growth Conditions
Escherichia coli was grown overnight at 37°C in Luria broth (Sangon, China) with gentle aeration or on Luria agar plates supplemented with 100 μg/mL of ampicillin and/or kanamycin when appropriate (Sigma-Aldrich, USA).
S. mutans UA159 was grown routinely as an overnight standing culture in brain-heart infusion (BHI) broth (Becton-Dickinson, USA) at 37°C in 5% CO2. The mutants were selected on Todd-Hewitt (TH) (Sigma-Aldrich, USA) agar plates after the strains were incubated overnight at 37°C in 5% CO2. Kanamycin (500 μg/mL) was added to the growth medium to maintain the selective pressure for the MS-gcrR-def mutant.
2.2. Construction of S. mutans gcrR-Knockout Mutant
The details of construction of gcrR-deficient mutant are in accordance with GMS900 generated by Idone . Briefly, the resulting amplicon is a 2220 bp fragment, which includes kanamycin-resistance (KanR) cassette (from pEGFP-N1 vector, 795 bp), gcrR upstream and downstream (720 and 705 bp from S. mutans UA159) at the end of KanR, and was then purified using a PCR purification kit (Qiagen, The Netherlands). The amplicon was then ligated to the pMD18-T simple plasmid to generate pMD-GK plasmid according to the manufacturer’s instructions (New England Biolabs, USA).
S. mutans UA159 cells were transformed with the final pMD-GK plasmid in the presence of competence-stimulating peptide according to a previously described method . Transformed colonies were selected on the TH-agar plate with 500 μg/mL of kanamycin after these colonies were incubated overnight at 37°C in 5% CO2.
2.3. Biofilm Formation and Adherence Assay in a Monospecies Biofilm Model
S. mutans wild-type and mutant strains were monitored to determine their adherence to the walls of 24-well cell culture plates following 2, 4, and 6 h growths in BHI supplemented with 2% sucrose. In brief, overnight bacteria cultures were first standardized to 1.0 optical density (OD470) by using fresh physiological saline. Then the bacterial suspensions were diluted at a ratio of 1 : 20 with fresh BHI that contains 2% sucrose and distributed in triplicate in sterile 24-well cell culture plates (NEST, China) with 2.0 mL of fresh medium. The plate was kept at 37°C in 5% CO2 for 2, 4, and 6 h (in triplicate). Bacterial growth was determined at 470 nm by using a microplate reader. Crystal violet staining was used to monitor biofilm formation as described previously .
2.4. Confocal Laser Scanning Microscopy (CLSM) Analysis
Wild-type S. mutans and MS-gcrR-def mutant standardized to 1.0 OD unit were diluted at a ratio of 1 : 20 in fresh BHI with 2% sucrose. The cells were then grown on glass coverslips placed in a sterile 6-well cell culture plate (NEST, China) in 5% CO2 at 37°C for 2, 4, 6, and 12 h. The biofilm samples were gently rinsed thrice with PBS to remove unattached cells, dried for 3 min, and stained with molecular probes SYTO 9 (a green fluorescent cell membrane stain; Invitrogen) and propidium iodide (a red fluorescent nucleic acid stain; Invitrogen). The stained samples were then examined via CLSM (ZEISS LSM 510 META; Carl Zeiss, Germany). Images were obtained from serial optical sections and captured at 488 nm. The Z section was used to record the biofilm thickness. The red and green fluorescence intensities were quantified using Image Pro-plus 6.0 (Media Cybernetics, USA).
2.5. The Ability of Acid Production
After the strains were standardized to 1.0 OD unit by using physiological saline, S. mutans wild-type and mutant strains were diluted at a ratio of 1 : 20 in fresh BHI supplemented with 1% sucrose in triplicate. For in vitro acid production, the initial pH of the culture was measured at a constant pH of 7.3 by using a pH meter after the cell suspensions of S. mutans, MS-gcrR-def were mixed. The decrease in pH levels for 16 h was measured again by using a pH meter to obtain the ΔpH of these cultures.
2.6. Competitive Test of Biofilm Formation In Vitro
Overnight S. mutans UA159 cultures and the MS-gcrR-def mutant were inoculated in BHI with water (control treatment) or kanamycin and then standardized to 1.0 OD unit (OD470) by using fresh physiological saline. The two bacterial suspensions were diluted at a ratio of 1 : 20 with fresh BHI and distributed in 4.0 mL aliquots into sterile 6-well cell culture plates to obtain two-bacterial biofilm cells at 37°C for 4, 6, 8, 11, and 24 h. Each well was gently rinsed with distilled water to remove loose bacteria. Firmly attached cells were scraped from the substrate by pipetting and then rinsed with distilled water to ensure that all of the cells were collected. Total DNA was extracted from the same numbers of cells in the control group and the test groups by using a DNA extract kit (Qiagen, The Netherlands). Total DNA was amplified in a TaKaRa SYBR Premix system. Amplification was performed using a 7500 real-time PCR system (Applied Biosystems, USA) according to the following thermal cycling protocol: initial denaturation at 95°C for 30 s and then followed by 40 cycles of the three steps (95°C for 5 s, 51°C for 30 s, and 72°C for 60 s). Standard curves were generated for each primer-template set with a series of standard S. mutans UA159 genomic DNAs (ATCC, USA) that were diluted 10-fold. The standard curves were then used to calculate the correlation coefficients and translate the concentration threshold (Ct) values into the relative DNA copy number. Ct is defined as the cycle in which SYBR green fluorescence is detected at a level above the background.
2.7. Competitive Test of Biofilm Formation In Vivo
Eighty specific pathogen-free (SPF) female SD rats (Medical Laboratory Animal Center, Wuhan, Hubei, China) at 18 days of age were chosen for the in vivo study. In order to facilitate the cariogenic bacterial planting, all the rats were fed with appropriate antibiotics (ampicillin, chloramphenicol, and carbenicillin 1.0 g/kg diet) for three consecutive days. these groups of six rats each were challenged with oral swabs saturated with CFU/mL of S. mutans UA159, MS-gcrR-def or mixture of those two strains in ratio of 1 : 1 per mL. Over the following 3 days, the rats were challenged repeatedly with fresh swabs of the appropriate strain, and on the next day after challenge, swab samples were collected and plated onto MSB agar plated to confirm colonization. All the groups were provided caries-promoting diet . Forty days after challenge, the rats were sacrificed, and their maxillary and mandibles were removed and subsequently processed for caries scores.
2.8. Statistical Analysis
Experimental data were analyzed on SPSS 16.0 software (SPSS, USA) and presented as means ± standard deviation. Two-group comparisons were performed using Student’s -test. value < 0.05 was considered statistically significant.
3.1. Confirmation of the gcrR Deletion in MS-gcrR-def
KanR transformants were screened to determine the deletion of the whole gcrR gene and the replacement with the KanR cassette as a result of double-crossover recombination. Chromosomal DNA was isolated from the selected transformants and UA159 progenitor, which was used as a template for PCR amplification with the P1/P2 and RT-gcrRF/RT-gcrRR primers (Table 1). The resulting amplicons (the gcrR upstream-KanR cassette junction and the part of the gcrR gene) were analyzed via agarose gel electrophoresis and their sizes were compared with those predicted after a successful allelic exchange event occurred (Figure 1). Nucleotide sequencing of the purified amplicons with the same primers confirmed the gcrR knockout and the KanR cassette insertion. The resulting mutant, which contains the gcrR upstream-KanR cassette junction and lacks the gcrR gene, was designated as MS-gcrR-def.
3.2. Evaluation of Biofilm Formation in Monospecies Biofilm Model
We test cell growth, adherence ability, and morphology of the strains to evaluate biofilm formation. While the adhesion ability of the gcrR-deficient mutants was stronger than that of the wild type (Figure 2). Furthermore, the difference in the early stage was greater than that in the late stage. Approximately 6- and 3-fold increases at 2 and 4 h were observed in the MS-gcrR-def gcrR knockout mutant compared with the wild type and the compensated mutant.
Biofilm structures were analyzed by CLSM. The top view and vertical section of the biofilm by S. mutans and gcrR deficient mutants are depicted. SYTO9 is a green fluorescent living cells membrane stain. Propidium iodide, in contrast, which is a red fluorescent nucleic acid stain penetrates only the cells with damaged membranes, thus visualizing only the dead microbes. We quantify the red and green fluorescence intensity, respectively (Figure 3). 2 h and 4 h mutant groups had conspicuous effect on increasing the number of living cells and the thickness of biofilm relative to UA159 and had statistical difference (). Accordingly, at the early stage (at 2 h and 4 h) MS-gcrR-def formed biofilms more quickly than UA159 and the biofilms were thicker relative to the wild type, which demonstrated MS-gcrR-def is a potential stronger adhesive to preempting tooth surface.
3.3. MS-gcrR-def Altered Acid Production Compared to UA159 Wild Type
To explore potential mechanisms of hypocariogenicity of MS-gcrR-def in competition with UA159, we examined the capacity of acid production of both strains, as well as the dominate gene ldh in metabolism (Figure 4). The initial pH of the culture when mixed with S. mutans and MS-gcrR-def was 7.3 and the final pH of the above two cultures was significantly lower than those values for the culture of MS-gcrR-def which were in the range of 4.11–4.13 after 16 h of incubation at 37°C. The MS-gcrR-def had a small average ΔpH which was substantially smaller than the average ΔpH of the wild type ().
3.4. MS-gcrR-def Was Competitive Than UA159 In Vitro
To certify the dominance in dual-species biofilm in replacement therapy, we inoculated the two strains into polystyrene plates with identical initial condition. The mutant exhibited an advantage over the wild type when these strains were cultured together. In particular, the gcrR-defective bacteria accounted for >90% in all of the adherent bacteria (Figure 5). Thus, the initial advantage continued to increase over time.
3.5. MS-gcrR-def Was Competitive Than UA159 in Germfree Rats
Since there is conspicuous superiority of MS-gcrR-def in the dual-bacteria biofilm, the mixing bacteria model in germfree rats is constructed to confirm its hypocariogenic ability in vivo. The rats are sacrificed 40 days after initial inoculation. The depth of carious lesion in both maxillary and mandibles involvement was scored for statistics (Figure 6). The duel-bacteria group and MS-gcrR-def monospecies group displayed significantly fewer enamel and dentinal lesions than UA159 wild-type group (). There was no significant difference in dental caries lesions between dual-bacteria group and MS-gcrR-def monospecies group ().
In the present study, we addressed the relationship both in vitro and in vivo of two strains, UA159 and MS-gcrR-def, and indicated a potential effector strain in bacterial replacement therapy. It was introduced to us with the increasing desire for natural products for health maintenance. For many years, replacement therapy has been considered a promising approach for the prevention of certain microbial infections . Parenterally administered competitive strains indiscriminately boycott pathogenic bacteria species associated with the host disease, resulting in formation of ecological volume exclusion and resistance development. Besides, the strains with the capacity of excluding colonization and/or infection could be considered as controlled microflora-composition modulation that otherwise occurs haphazardly in nature .
S. mutans is by far the most common pathogen found in dental caries and may get spontaneous mutation in environmental induction. Directly implant the harmless bacteria which are strongly competitive with S. mutans, leading to achieving tailor-made protection for the host against it. Since the effector strain is closely contacted to the host, herd protection through natural transmission might be increased too. Jeffrey Hillman’s group generate a hypocariogenic strain which affects the acid production of S. mutans by using recombinant DNA methodology and persistently continue the research for 20 years . Mutant only exhibiting defects in acid production and hypocariogenicity in animal models are unlikely to compete successfully with wild-type strains for initial plaque locations . In this case, we contemplate to make an appropriate gene modification in S. mutans to develop the effector strain with ecological volume exclusion and low acid production.
Glucan-binding lectin (GBL), which enables bacteria to aggregate by binding the α-1,6-glycosidic linkages, is ubiquitous on the S. mutans surface. GBL is an adhesin and can be isolated from many S. mutans subtypes . With the help of adhesions such as GBL, S. mutans can synthesize many kinds of glucan to form a wrap of mucosal fluid, which promotes its tight adherence to the tooth surface. Although different opinions on the mechanism by which GBL functions have been presented, GBL has a very important function in the formation of dental plaque and adherence of S. mutans . The gcrR gene functions as a negative transcriptional regulator of the gbpC gene, which encodes the S. mutans GBL. Some researchers revealed that the gcrR expression product shares a high homology with the signaling molecule of the density inductance system, which may be involved in the regulation of the GBL expression. For instance, Sato et al.  revealed the downregulation of gbpC gene by gcrR gene. On the contrary, the gcrR gene knockout results in the overexpression of GBL. In the study of Idone et al., RT-PCR demonstrated an increase in gtfD, gbpC gene of strain GM900, leading to augment in sucrose-dependent adherence. Our group did the same research on MS-gcrR-def and got the identical result (data not shown). Interestingly, they suggested the aggregate of GM900 increase in vitro, while it reveals compromise in their ability to colonize in vitro model of tooth surface and to rat molars than the wild type. We have the converse result to the point. In our research, comparing with UA159, MS-gcrR-def had evident superiority in sucrose-dependent adherence to borosilicate glass and absolutely dominated in the biofilm construction, indicating strong competitiveness of the former by the weight of evidence. It may be due to the strain of S. mutans and culture method.
In this case, the deficiency of gene gcrR results in consecutive descent in pH value of MS-gcrR-def cells, as well as the biofilm it forms. In 2008, Dunning and colleagues showed that GMS901, the S. mutans mutant, which harbors insertion-deletion mutation in gcrR, is acid sensitive and has a significantly lower acid tolerance response (ATR) compared with the wild-type progenitor strain S. mutans UA159 . They suggested gcrR could increase the expression of gene ffh and gene atpA/E which related to ATR and may modulate the pH value through proton-translocating ATPase on the cell membrane . In the acidic environment, it is crucial to maintain transmembrane pH values so that the intracellular pH compared to the environment is alkaline, which is benefit for the glycolytic activity of the cariogenic bacteria .
Taken together, MS-gcrR-def showed reduced acid production and significantly enhanced adhesion ability at the early stage, which might confer it an absolute advantage in the competition with wild type. These findings suggest that MS-gcrR-def is a promising effect strain in place of UA159. In the replacement therapy, even if the wild-type strain interference cannot be avoided, the mutant, with its strong early colonization ability, is still able to become the dominant bacteria on the surface of tooth and reduce the incidence of dental caries.
Wenting Pan and Tiantian Mao contributed equally to this study.
The work was supported financially by Grant no. 20100217 from Department of Public Health, China, and Grant no. 30973312 and 81201260 from National Natural Science Foundation of China.
- J. Tang, Y. Yu, and Y. Ma, “The epidemic tendency of dental caries prevalence of school students from 1991 to 2005 in China,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 30, no. 1, pp. 132–137, 2010.
- J. D. Hillman, “Replacement therapy for the control of dental caries,” The New Dentist, vol. 10, no. 6, pp. 24–27, 1980.
- B. Krasse, H. V. Jordan, S. Edwardsson, I. Svensson, and L. Trell, “The occurrence of certain—caries-inducing” streptococci in human dental plaque material. With special reference to frequency and activity of caries,” Archives of Oral Biology, vol. 13, no. 8, pp. 911–918, 1968.
- J. Kreth, Y. Zhang, and M. C. Herzberg, “Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans,” Journal of Bacteriology, vol. 190, no. 13, pp. 4632–4640, 2008.
- J. M. Tanzer, A. Thompson, K. Sharma, M. M. Vickerman, E. M. Haase, and F. A. Scannapieco, “Streptococcus mutans out-competes Streptococcus gordonii in vivo,” Journal of Dental Research, vol. 91, no. 5, pp. 513–519, 2012.
- J. M. Tanzer, A. B. Kurasz, and J. Clive, “Competitive displacement of mutans streptococci and inhibition of tooth decay by Streptococcus salivarius TOVE-R,” Infection and Immunity, vol. 48, no. 1, pp. 44–50, 1985.
- W. J. Loesche, “Role of Streptococcus mutans in human dental decay,” Microbiological Reviews, vol. 50, no. 4, pp. 353–380, 1986.
- J. D. Hillman, T. A. Brooks, S. M. Michalek, C. C. Harmon, J. L. Snoep, and C. C. van der Weijden, “Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries,” Infection and Immunity, vol. 68, no. 2, pp. 543–549, 2000.
- V. Idone, S. Brendtro, R. Gillespie et al., “Effect of an orphan response regulator on Streptococcus mutans sucrose-dependent adherence and cariogenesis,” Infection and Immunity, vol. 71, no. 8, pp. 4351–4360, 2003.
- Y. Sato, Y. Yamamoto, and H. Kizaki, “Cloning and sequence analysis of the gbpC gene encoding a novel glucan-binding protein of Streptococcus mutans,” Infection and Immunity, vol. 65, no. 2, pp. 668–675, 1997.
- C. Liu, R. J. Worthington, C. Melander, and H. Wu, “A new small molecule specifically inhibits the cariogenic bacterium Streptococcus mutans in multispecies biofilms,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2679–2687, 2011.
- C. Liu, M. Fan, Z. Bian, Z. Chen, and Y. Li, “Effects of targeted fusion anti-caries DNA vaccine pGJA-P/VAX in rats with caries,” Vaccine, vol. 26, no. 51, pp. 6685–6689, 2008.
- H. W. Florey, “The use of micro-organisms for therapeutic purposes,” Yale Journal of Biology and Medicine, vol. 19, pp. 101–117, 1946.
- R. P. Allaker and C. W. I. Douglas, “Novel anti-microbial therapies for dental plaque-related diseases,” International Journal of Antimicrobial Agents, vol. 33, no. 1, pp. 8–13, 2009.
- J. D. Hillman, “Genetically modified Streptococcus mutans for the prevention of dental caries,” Antonie van Leeuwenhoek, vol. 82, no. 1–4, pp. 361–366, 2002.
- J. H. Sun, Q. A. Xu, and M. W. Fan, “A new strategy for the replacement therapy of dental caries,” Medical Hypotheses, vol. 73, no. 6, pp. 1063–1064, 2009.
- M. J. Pallen, A. C. Lam, M. Antonio, and K. Dunbar, “An embarrassment of sortases—a richness of substrates?” Trends in Microbiology, vol. 9, no. 3, pp. 97–101, 2001.
- S. Schauder, K. Shokat, M. G. Surette, and B. L. Bassler, “The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule,” Molecular Microbiology, vol. 41, no. 2, pp. 463–476, 2001.
- D. W. Dunning, L. W. McCall, W. F. Powel et al., “SloR modulation of the Streptococcus mutans acid tolerance response involves the GcrR response regulator as an essential intermediary,” Microbiology, vol. 154, no. 4, pp. 1132–1143, 2008.
- J. A. Gutierrez, P. J. Crowley, D. G. Cvitkovitch et al., “Streptococcus mutans ffh, a gene encoding a homologue of the 54 kDa subunit of the signal recognition particle, is involved in resistance to acid stress,” Microbiology, vol. 145, part 2, pp. 357–366, 1999.
- A. Hasona, K. Zuobi-Hasona, P. J. Crowley et al., “Membrane composition changes and physiological adaptation by Streptococcus mutans signal recognition particle pathway mutants,” Journal of Bacteriology, vol. 189, no. 4, pp. 1219–1230, 2007.